Summary:
- Lantheus, a leading provider of diagnostic imaging technologies, will be presenting at the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting.
- The presentations will focus on the company's innovative diagnostic imaging solutions, including their radiopharmaceutical products used in nuclear medicine procedures.
- These presentations will showcase Lantheus' commitment to advancing the field of diagnostic imaging and providing healthcare professionals with cutting-edge tools to improve patient care.